Parity as an Independent Prognostic Factor in Malignant Mixed Mesodermal Tumors of the Endometrium

Author： Marth C.   Windbichler G.   Petru E.   Dirschlmayer W.   Obermair A.   Czerwenka K.   Muller-Holzner E.   Dapunt O.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.64, Iss.1, 1997-01, pp. : 121-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Expression of Epidermal Growth Factor Receptor, HER-2/ Neu, p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

By Swisher E.M.   Gown A.M.   Skelly M.   Ek M.   Tamimi H.K.   Cain J.M.   Greer B.E.   Muntz H.G.   Goff B.A.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 81-88

Academic Press

Access to resources Recommend Favorite

Malignant mixed mesodermal tumours - biology and clinical aspects

By Gourley C.   Al-Nafussi A.   Abdulkader M.   Smyth J.F.   Gabra H.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1437-1446

Elsevier

Access to resources Recommend Favorite

Coexistent Choriocarcinoma and Malignant Mixed Mesodermal Tumor of the Uterus

By Nguyen C.P.   Levi A.W.   Montz F.J.   Bristow R.E.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 499-503

Elsevier

Access to resources Recommend Favorite

Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors

By                      

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2345-2353

Spandidos Publications

Access to resources Recommend Favorite

Malignant Mixed Mesodermal Ovarian Tumor Treatment and Prognosis: A 20-Year Experience

By Le T.   Krepart G.V.   Lotocki R.J.   Heywood M.S.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite